CLUSTER filed Aug 5, 2026 at 21:35 ET
Seven Natera insiders, including the CEO, CFO, Executive Chairman, and President of Clinical Diagnostics, sold a total of $1.70M in open-market sales over a 7-day window. This is a broad-based cluster involving the entire C-suite and a director, with no insider buying to offset. While the total value is only ~0.004% of Natera's $39.4B market cap (trivial by proportionality), the unanimity and seniority of the selling group is notable and warrants attention for potential upcoming news or a peak in the stock's recent rally.